尿酸与急性ST段抬高型心肌梗死患者急诊PCI术后冠脉血流及预后的相关性研究
本文关键词:尿酸与急性ST段抬高型心肌梗死患者急诊PCI术后冠脉血流及预后的相关性研究 出处:《南昌大学》2014年硕士论文 论文类型:学位论文
更多相关文章: 尿酸 急性ST段抬高型心肌梗死 急诊PCI 临床预后
【摘要】:研究背景:流行病学显示,尿酸水平升高与心血管疾病相关,尿酸是普通人群、冠心病患者不良预后的独立预测因子。研究发现,尿酸升高与冠脉血流受损相关。但是目前尚不清楚尿酸是否能预测急性ST段抬高型心肌梗死(acuteST-elevation myocardial infarction STEMI)患者急诊经皮冠状动脉介入治疗(primary percutaneous coronary intervention PCI)术后冠脉血流受损、以及尿酸是否与STEMI患者短期和长期预后独立相关。 研究目的:对住院期间尿酸水平与STEMI患者急诊PCI后冠脉血流以及短期和长期预后的相关性进行研究。 研究方法:选取2010年01月至2013年6月就诊于海淀医院、发病在12h内的STEMI并且行急诊PCI的患者。根据实验室检测的尿酸结果将STEMI患者分成两组:高尿酸组(其中男性420umol/l,女性360umol/l),其中男性24例(77.4%)、女性7例(22.6%);正常尿酸组(其中男性≤420umol/l,女性≤360umol/l),其中男性82例(75.9%)、女性26例(24.1%)。所有患者PCI术后收入CCU进一步治疗。入院后采集所有患者的一般情况、实验室检查结果、经胸超声心脏彩超及冠状动脉造影结果,记录患者住院期间死亡和主要不良心血管情况。患者出院6个月后进行随访,收集患者PCI术后6个月的死亡和主要不良心血管情况。多变量分析住院期间尿酸水平与STEMI患者急诊PCI术后冠脉血流受损相关性、以及尿酸水平与STEMI患者住院期间和PCI术后6个月死亡和主要不良心血管事件的相关性。 研究结果: 本研究共纳入139名行急诊PCI的STEMI患者,其中男性106例(76.3%),女性33例(23.7%)。高尿酸组31例(22.3%),正常尿酸组108例(77.7%)。 高尿酸组高血压发病率(54.8%vs32.4%,PO.05)、陈旧心肌梗死发病率(19.4%vs8.3%,PO.05)、多支血管病变发病率(61.3%vs37.0%,PO.05)显著高于正常尿酸组;入院后高尿酸组与正常尿酸组心功能KillipⅠ级(54.8%vs73.1%,P=0.06)、KillipⅡ级(12.9%vs18.5%,P=0.47)无统计学差异,但是高尿酸组KillipⅢ级(16.1%vs3.7%,PO.05)、KillipⅣ级(16.1%vs4.6%,PO.05)显著高于正常尿酸组。经胸超声心动图显示,高尿酸组患者的左室射血分数(LVEF)显著低于正常尿酸组(49±15%vs54±11%,PO.05)。冠脉造影检查显示,高尿酸组和低尿酸组无复流(TIMI血流0、1、2级)发生率也存在统计学差异(29.0%vs10.2%,PO.05)。高尿酸组患者住院期间主要不良心血管事件显著高于正常尿酸组(25.8%vs7.4%,PO.05);两组6个月主要不良心血管事件也存在统计学差异(25.2%vs23.1%,PO.05)。多变量分析表明,在校正了影响因素后,住院期间尿酸水平是STEMI患者急诊PCI术后冠脉血流受损、住院期间不良心血管事件的独立危险因素(分别0R=1.0995%CI1.02-1.18, PO.05;0R=1.0995%CI1.02-1.12, PO.05)。 研究结论: 住院期间尿酸水平与STEMI患者急诊PCI术后冠脉血流受损独立相关。此外,尿酸是STEMI患者急诊PCI术后短期主要不良心血管事件的独立危险因素。因此我们的研究证实,,作为一项简便、快捷、低廉、可靠的检查手段,尿酸不但能预测STEMI患者急诊PCI术后冠脉血流受损,还是评估STEMI患者危险分层有效的标记物。
[Abstract]:Background: epidemiologic studies suggest that elevated levels of uric acid, uric acid is associated with cardiovascular disease, the general population, independent predictors of poor prognosis of patients with coronary heart disease. The study found that uric acid is associated with impaired coronary flow. But it is unclear whether uric acid can predict acute ST elevation myocardial infarction (acuteST-elevation myocardial infarction STEMI) patients after emergency percutaneous coronary intervention (primary percutaneous coronary intervention PCI) impaired coronary blood flow after operation, and whether uric acid independently associated with STEMI in patients with short-term and long-term prognosis.
Objective: To study the relationship between the level of uric acid during hospitalization and the coronary blood flow after emergency PCI and the short-term and long-term prognosis in patients with STEMI.
Methods: from 2010 to June 2013 in Haidian Hospital from 01 months, the incidence of 12h in the STEMI and emergency PCI patients. According to the results of laboratory tests and uric acid STEMI patients were divided into two groups: high uric acid group (male 420umol/l, female 360umol/l), among which 24 cases were male (77.4%), 7 females (22.6%); normal uric acid group (male = 420umol/l, female 360umol/l), among which 82 cases were male (75.9%), 26 cases were female (24.1%). All the patients with PCI after CCU treatment. Further income generally collected after admission in all patients, results of laboratory examination, transthoracic echocardiography and coronary angiography records of hospitalized patients, adverse cardiovascular death and major. During the follow-up of patients 6 months after discharge, death and major adverse cardiovascular conditions for 6 months were collected after PCI. Multivariate analysis of uric acid during hospitalization The correlation between level and coronary artery blood flow impairment after emergency PCI operation in STEMI patients, and the correlation between uric acid level and death and major adverse cardiovascular events in STEMI patients during hospitalization and 6 months after PCI were also analyzed.
The results of the study:
A total of 139 STEMI patients undergoing emergency PCI were enrolled in this study, including 106 men (76.3%), 33 women (23.7%), 31 patients (22.3%) in hyperuricemia group, and 108 patients (77.7%) in normal uric acid group.
High uric acid group the incidence of hypertension (54.8%vs32.4%, PO.05), old myocardial infarction incidence rate (19.4%vs8.3%, PO.05), multivessel disease incidence rate (61.3%vs37.0%, PO.05) was significantly higher than that in normal uric acid group; after admission, high uric acid group and normal uric acid group Killip heart function grade (54.8%vs73.1%, P=0.06), Killip (grade II 12.9%vs18.5%, P=0.47) had no significant difference, but the high uric acid group of Killip III (16.1%vs3.7%, PO.05), Killip grade (16.1%vs4.6%, PO.05) was significantly higher than that in normal uric acid group. Transthoracic echocardiography showed high uric acid group of patients with left ventricular ejection fraction (LVEF) was significantly lower than the normal uric acid group (49 + 15%vs54 + 11%, PO.05). Coronary angiography showed high uric acid group and low uric acid group of no reflow (TIMI flow 0,1,2) incidence rate there were significant difference (29.0%vs10.2%, PO.05). The main high uric acid group of patients during hospitalization To adverse cardiovascular events was significantly higher than that in normal uric acid group (25.8%vs7.4%, PO.05); the two group of 6 months of major adverse cardiovascular events there were significant difference (25.2%vs23.1%, PO.05). Multivariate analysis showed that in the correction factors, during the period of hospitalization is uric acid impaired coronary blood flow in patients with STEMI after emergency PCI, independent risk period the factors of adverse cardiovascular events in hospital (respectively 0R=1.0995%CI1.02-1.18, PO.05; 0R=1.0995%CI1.02-1.12, PO.05).
The conclusions are as follows:
During hospitalization, uric acid and emergency patients after PCI STEMI impaired coronary flow independently. In addition, uric acid is the independent risk factors of short-term major adverse cardiovascular events in STEMI patients after emergency PCI. Therefore our research confirms that as a simple, fast, inexpensive, reliable inspection method, not only can predict the uric acid in patients with STEMI after emergency PCI impaired coronary flow, or assess the risk stratification of STEMI patients and effective marker.
【学位授予单位】:南昌大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R542.22
【共引文献】
相关期刊论文 前10条
1 何汉康;龙卫平;陈剑;石磊;;STEMI直接PCI术后ST段无回落的临床预后及其危险因素[J];华夏医学;2013年04期
2 汪菊风;;PCI治疗急性冠脉综合征104例术后护理[J];西部中医药;2013年09期
3 Bibek Poudel;Binod Kumar Yadav;Arun Kumar;Bharat Jha;Kanak Bahadur Raut;;Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population:A hospital based cross sectional study[J];Asian Pacific Journal of Tropical Biomedicine;2014年01期
4 王真真;刘地川;蔡敏;吴健;;别嘌呤醇对慢性心衰大鼠心功能的改善作用[J];第三军医大学学报;2014年10期
5 苏晓蓉;廖伟;刘建生;;姜黄素减轻心肌缺血-再灌注损伤的实验研究[J];当代医学;2014年33期
6 张如婷;高学文;王萍;;急性冠脉综合征患者血尿酸与内皮素的临床意义[J];内蒙古医学杂志;2011年S5期
7 闫婕;陶慧;林发全;;血尿酸水平与血管内皮细胞损伤关系的研究进展[J];中华老年心脑血管病杂志;2013年09期
8 周红;刘弈彤;梁小燕;戚晓红;;硫化氢抑制局部肾素水平影响动脉粥样硬化的研究[J];南京医科大学学报(自然科学版);2013年09期
9 刘永荣;王丹;邱春光;韩战营;张菲斐;;别嘌醇预处理对经皮冠状动脉介入治疗围手术期心肌损伤的影响[J];临床心血管病杂志;2014年02期
10 张俊修;霍旺;王朋;李绍旦;刘毅;杨明会;;冠状动脉结扎(孙络疏失)模型大鼠血浆内皮细胞活性因子及微血管舒缩因子的动态变化研究[J];环球中医药;2014年02期
相关会议论文 前1条
1 张海涛;杨跃进;程宇彤;康晟;赵京林;孟亮;田毅;张燕婉;叶珏;;通心络预给药2h对猪急性心肌梗死再灌注后心肌无再流和细胞因子变化的影响[A];首届中西医血管病学大会论文汇编[C];2013年
相关博士学位论文 前10条
1 刘琳;肾脏管球反馈在高尿酸诱导高血压发病中可能的机制[D];北京协和医学院;2013年
2 陈明;基于AngⅡ上调p38MAPK通路介导的炎症反应与无患子皂苷降压作用及机制的相关性研究[D];安徽医科大学;2013年
3 吕琴;血清尿酸与2型糖尿病及糖尿病肾病关系的研究[D];华中科技大学;2013年
4 刘晓磊;ALCAT1介导心肌肥厚的病理进程及调控线粒体氧化应激和自噬的机制[D];中南大学;2012年
5 冯春光;主动脉内球囊反搏对再灌注治疗后急性前壁心肌梗死的治疗研究[D];苏州大学;2013年
6 杨宇;经皮冠状动脉介入治疗术对稳定性心绞痛患者冠状动脉微循环影响的研究[D];南方医科大学;2014年
7 于静;能谱CT定量评估猪急性缺血—再灌注型MI[D];天津医科大学;2014年
8 顾晓龙;急性心肌梗死合并心力衰竭再灌注后早期应用洋地黄的近期疗效和安全性研究[D];南方医科大学;2014年
9 张军霞;尿酸调控脂肪组织RAS及其与肥胖性高血压的相关性[D];第三军医大学;2014年
10 秦小飞;慢复流或无复流现象和粥样斑块易损性的原因分析及VH-IVUS在慢复流或无复流现象中的预测价值[D];郑州大学;2014年
相关硕士学位论文 前10条
1 张瑞环;高龄冠心病患者脂类代谢与冠状动脉粥样硬化相关性分析及急性心肌梗死介入治疗近期疗效分析[D];南方医科大学;2012年
2 赵茹;实时心肌声学造影定量评价缺血后适应对微循环的影响[D];苏州大学;2013年
3 张会芳;不同性别2型糖尿病患者血尿酸与颈动脉内中膜厚度的相关性研究[D];河北医科大学;2013年
4 高晓婷;腹膜透析患者血尿酸、同型半胱氨酸和超敏C反应蛋白的变化及其意义[D];河北医科大学;2013年
5 李占虎;山莨菪碱联合缺血后适应对ST段抬高心肌梗死患者直接经皮冠脉介入术后心肌灌注的影响[D];河北医科大学;2013年
6 杨静;尼可地尔术前顿服对择期PCI围手术期的心肌保护作用[D];河北医科大学;2013年
7 刘洋;强化阿托伐他汀上调CD4+T淋巴细胞miRNA-21防治冠脉介入治疗术后心肌损伤的研究[D];广西医科大学;2013年
8 张晓曼;血小板相关因子和hs-CRP与急性ST段抬高心肌梗死患者直接PCI术后无复流的相关性研究[D];河北医科大学;2013年
9 牛洁婷;冠脉内预防性应用山莨菪碱对急性下壁心肌梗死患者直接经皮冠脉介入治疗后冠脉微循环的影响[D];河北医科大学;2013年
10 刘霞;QRS积分预测ST段抬高型心肌梗死急诊PCI近期预后的意义[D];大连医科大学;2012年
本文编号:1374768
本文链接:https://www.wllwen.com/yixuelunwen/jjyx/1374768.html